Show source-provided references
8. Analysis of Recovery Trajectories in Degenerative Cervical Myelopathy to Facilitate Improved Patient Counseling and Individualized Treatment Recommendations
10. The Prevalence and Phenotype of Activated Microglia/Macrophages Within the Spinal Cord of the Hyperostotic Mouse (twy/twy) Changes in Response to Chronic Progressive Spinal Cord Compression: Implications for human Cervical Compressive Myelopathy
10.1371/journal.pone.0064528 ↗12. Long‐term Dynamics of the Spinal Cord Injury Neuroinflammatory Response and Sensory Dysfunction in Female Mice
10.1016/j.bbi.2025.05.024 ↗13. The Quiet Giant: Identification, Effectors, Molecular Mechanism, Physiological and Pathological Function in mRNA 5‐methylcytosine Modification
10.7150/ijbs.101337 ↗17. Tetramethylpyrazine Promotes Functional Recovery After Spinal Cord Injury by Regulating 5‐Methylcytosine RNA Modification via the NSUN2‐XBP1 Axis
10.1007/s12035-025-05520-1 ↗18. Molecular Characterization and Clinical Characteristics of m5C‐Based RNA Methylation in Spinal Cord Injury: Validated by qPCR
10.1155/2022/5433860 ↗19. AGAPIR: A Novel PIWI‐Interacting RNA Enhancing Post‐Decompression Angiogenesis in Degenerative Cervical Myelopathy
20. Basso Mouse Scale for Locomotion Detects Differences in Recovery After Spinal Cord Injury in Five Common Mouse Strains
10.1089/neu.2006.23.635 ↗25. Rapid and Efficient Enrichment of Mouse Spinal Cord Microglia
27. Effectiveness of Surgical Decompression in Patients With Degenerative Cervical Myelopathy: Results of the Canadian Prospective Multicenter Study
10.1093/neuros/nyab295 ↗28. A Clinical Prediction Rule for Functional Outcomes in Patients Undergoing Surgery for Degenerative Cervical Myelopathy
30. Blood Spinal Cord Barrier Disruption Recovers In Patients With Degenerative Cervical Myelopathy After Surgical Decompression: A Prospective Cohort Study
10.1038/s41598-023-34004-2 ↗31. Network Pharmacology Analysis and Animal Experiment Validation of Neuroinflammation Inhibition by Total Ginsenoside in Treating CSM
10.1016/j.phymed.2023.155073 ↗32. Mir21 Modulates Inflammation and Sensorimotor Deficits in Cervical Myelopathy: Data From Humans and Animal Models
10.1093/braincomms/fcaa234 ↗33. Targeting RelA/NLRP3/CCL3 Axis Mitigates Microglia Inflammatory Response and Promotes Recovery After Spinal Cord Injury
10.1016/j.bbi.2025.07.015 ↗34. TET1 mediated m5C Modification of RelB Aggravates Cerebral Ischemia/Reperfusion‐induced Neuroinflammation Through Regulating Microglia Polarization
10.1016/j.cellsig.2024.111210 ↗35. Cytosine Methylation of Mature microRNAs Inhibits Their Functions and Is Associated With Poor Prognosis in Glioblastoma Multiforme
10.1186/s12943-020-01155-z ↗39. CIGAR‐seq, a CRISPR/Cas‐based method for unbiased screening of novel mRNA modification regulators
10.15252/msb.202010025 ↗41. Modulation of Microglia Polarization Through Silencing of NF‐κB p65 by Functionalized Curdlan Nanoparticle‐Mediated RNAi
10.1021/acsami.9b23004 ↗42. DJ‐1 Inhibits Microglial Activation and Protects Dopaminergic Neurons In vitro and In vivo Through Interacting With Microglial p65
10.1038/s41419-021-04002-1 ↗43. Morin Regulates M1/M2 Microglial Polarization via NF‐κB p65 to Alleviate Vincristine‐Induced Neuropathic Pain
10.2147/DDDT.S459757 ↗44. Inflammation, Apoptosis and Autophagy as Critical Players in Vascular Dementia
46. AO Spine Clinical Practice Recommendations for Diagnosis and Management of Degenerative Cervical Myelopathy: Evidence Based Decision Making—A Review of Cutting Edge Recent Literature Related to Degenerative Cervical Myelopathy
10.1177/21925682251331050 ↗47. Pharmacological Treatment of Degenerative Cervical Myelopathy: A Critical Review of Current Evidence
10.14245/ns.2448140.070 ↗